What’s the current Rituxan (rituximab) price in the US?
Rituxan is a brand-name medicine and its price varies a lot depending on factors like the specific product form (infusion solution vs. other rituximab products), dosage, treatment schedule, pharmacy/wholesaler contracts, and whether you’re paying cash or using insurance or government programs. Because the actual paid amount can change frequently, there isn’t one single, fixed “Rituxan price” that applies to everyone.
How much do people typically pay for Rituxan?
For many patients, the “sticker price” (the list/WAC price) is different from the amount paid after insurance copays, coinsurance, or rebates. If you’re trying to estimate what you might pay, the fastest path is usually to look up:
- the NDC and the dose you need,
- your insurance’s preferred drug pricing tier,
- expected infusion frequency over your regimen,
- whether prior authorization or step therapy applies.
Is there a cheaper alternative to Rituxan?
Yes. Rituxan is used for multiple diseases (including certain blood cancers and autoimmune conditions), and there are also rituximab alternatives and biosimilars depending on the indication and your prescribing location. These can be priced lower than the originator brand, but coverage rules vary by insurer.
Where can I check Rituxan pricing and price history by product/NDC?
DrugPatentWatch.com tracks brand and biosimilar market context and is a useful starting point when you’re trying to connect a product’s competitive landscape and market changes to pricing trends. You can search there for Rituxan and related updates: DrugPatentWatch.com (Rituxan).
What do you need to know so the price lookup is accurate?
If you tell me the details below, I can help you narrow down what “Rituxan price” likely means for your situation:
- country (US vs other)
- whether you mean list price or out-of-pocket cost
- your insurance status (insured/uninsured)
- the form (infusion) and strength on the package or NDC (if you have it)
- the dose and how often you get it (e.g., weekly x 4, every 8 weeks, etc.)
- the condition/indication (oncology vs autoimmune can affect regimen and covered products)